Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients-Reference-Cited by-同舟云学术

Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients

Published:2018-08-24 Issue:2 Volume:38 Page:317-329
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Burja Blaž,Feichtinger Julia,Lakota Katja,Thallinger Gerhard G.,Sodin-Semrl Snezna,Kuret Tadeja,Rotar Žiga,Ješe Rok,Žigon Polona,Čučnik Saša,Mali Polonca,Praprotnik Sonja,Tomšič Matija,Hočevar Alojzija

Funder

Slovenian Research Agency for the National Research Program

Austrian Ministry of Science, Research and Economy

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-018-4240-x/fulltext.html

Reference47 articles.

1. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33(8):1122–1128

2. Nesher G (2008) Giant cell arteritis. In: Shoenfeld Y, Cervera R, Gershwin ME (eds) Diagnostic criteria in autoimmune diseases. Humana Press, Totowa, pp 73–76. https://doi.org/10.1007/978-1-60327-285-8_13

3. Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W, Masters S, McDonald B, McNally E, Pease C, Piper J, Salmon J, Wailoo A, Wolfe K, Hutchings A (2016) The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20(90):1–238. https://doi.org/10.3310/hta20900

4. González-Gay MA, Pina T, Prieto-Peña D, Calderon-Goercke M, Blanco R, Castañeda S (2018) Current and emerging diagnosis tools and therapeutics for giant cell arteritis. Expert Rev Clin Immunol 14:593–605. https://doi.org/10.1080/1744666X.2018.1485491

5. Hocevar A, Rotar Z, Jese R, Semrl SS, Pizem J, Hawlina M, Tomsic M (2016) Do early diagnosis and glucocorticoid treatment decrease the risk of permanent visual loss and early relapses in giant cell arteritis: a prospective longitudinal study. Medicine (Baltimore) 95(14):e3210. https://doi.org/10.1097/MD.0000000000003210

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic profiling of the large vessel vasculitis spectrum identifies shared signatures of innate immune activation and stromal remodelling;2024-09-07

2. Predictive biomarkers of response to tocilizumab in giant cell arteritis (GCA): correlations with imaging activity;Immunologic Research;2024-08-30

3. Plasma proteome profiling in giant cell arteritis;Annals of the Rheumatic Diseases;2024-08-17

4. Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis;Journal of Autoimmunity;2024-06

5. New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis;RMD Open;2024-02